Pioneering the Future in Pharmaceuticals

In the realm of GMP compliance, continuous verification and quality testing of pharmaceuticals is essential. However, does this always entail spending millions on testing annually? Must it involve destructive testing of market-ready products? We challenge these notions and offer an alternative: "parametric approvals." Embracing Industry 4.0 in the pharmaceutical domain? With AC&C, it's not just a possibility, but a reality!

Quality management with QA (assurance), QC (control) and improvement. Standardisation and certification concept. Compliance to regulations and standards. Manager or auditor working on computer.

Challenge

Traditional batch releases in the pharmaceutical industry heavily rely on costly and time-consuming destructive testing methods. The expenses associated with these approval processes can quickly escalate to thousands of euros per test, depending on the specific drug. Our mission is to introduce a paradigm shift by enabling releases based on product and production parameters, eliminating the need for destructive testing altogether. Join us in embracing a more efficient and cost-effective approach to batch releases without compromising on quality.

Solution

When seeking approval for an application device, we analyze the product and production data obtained from critical production runs to assess their predictability in relation to the quality of the end product. By leveraging advanced data analysis techniques, we provide insights that enable a more accurate evaluation of product quality during the approval process. Embrace our solution to enhance predictability and streamline the path to successful approvals for your application devices.

Scientists in a laboratory recording data. Both working beside a special piece of machinery called a Mass spectrometry (MS) , an analytical chemistry technique that helps identify the amount and type of chemicals present in a sample by measuring the mass-to-charge ratio and abundance of gas-phase ions
A businessman selecting a Cost Control Concept button

Results

Our comprehensive studies have empowered the pharmaceutical company to significantly reduce, and in some cases eliminate, the need for destructive testing. This breakthrough approach has led to remarkable cost savings, with testing and scrap costs slashed by up to 80%. Embrace our solution to unlock unparalleled efficiency and cost optimization in your pharmaceutical operations.

More Cases

Take Action Now!

Are you seeking ways to streamline your quality assurance efforts? Look no further! Our team is eager to unveil the myriad possibilities available to you. Don't hesitate any longer—reach out to us today and discover a more efficient path towards excellence.